Application and difficulties of deep learning in drug target discovery

Abstract

The integration of deep learning technology within the domain of drug target discovery represents a cutting-edge approach in the pharmaceutical sciences. This paper delves into the methods and prevailing issues associated with the application of deep learning in the identification of new drug targets. We initiate with an exposition of the fundamental concepts and methodologies underpinning deep learning, subsequently illuminating its utilization in the realm of drug target discovery. Specific attention is given to the deployment of architectures like convolutional neural networks (CNNs) and recurrent neural networks (RNNs) among others.

By interpreting experimental outcomes, it has been discerned that deep learning potentially enhances the precision of identifying drug targets. Nonetheless, this technological arena is not devoid of challenges. A significant hurdle lies in the interpretability of the models—understanding why and how these models arrive at their conclusions is often non-trivial. Moreover, the efficacy of deep learning is heavily reliant on the quality and volume of the datasets employed; insufficient or poor-quality data can severely impede the performance and reliability of predictive models.Through this inquiry, we aim to furnish novel insights into the utilization of deep learning for drug target discovery and underscore the challenges that must be addressed. The perspectives offered herein are vital to propel the progress of this burgeoning field, paving the way for more effective and efficient drug discovery processes.